Caring for patients with prosthetic heart valves

Cleveland Clinic Journal of Medicine

Volumn 69, Issue 1, 2002, Pages 75-87

  Bettadapur, Monica S ^a   Griffin, Brian P ^a   Asher, Craig R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EMBOLISM; ENDOCARDITIS; HEART VALVE PROSTHESIS; HEMOLYTIC ANEMIA; HUMAN; PATIENT CARE; PROSTHESIS FAILURE;

EID: 0036146546     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.69.1.75     Document Type: Article

References (59)

1. Prosthetic heart valves
2. Up to seven years of experience with the Ross procedure in patients>60 years of age
3. Echocardiographic assessment of heart valves
4. Incidence of emboli with cloth-covered Starr-Edwards valve without anticoagulation and with varying forms of anticoagulation. Analysis of 183 patients followed for 3 1/2 years
5. Thromboembolic complications of prosthetic cardiac valves
6. Factors affecting thromboembolism associated with prosthetic heart valves
7. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses
8. Risk factors for the development of prosthetic valve endocarditis
9. Prosthetic valve endocarditis
10. Prevention of bacterial endocarditis. Recommendations by the American Heart Association
11. Low molecular weight heparin after mechanical heart valve replacement
12. Low-molecular-weight heparin for prosthetic heart valves: Treatment failure
13. Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature
14. Guidelines for the management of patients with valvular heart disease: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Patients with Valvular Heart Disease)
15. Pregnancy and mechanical valve prostheses: A high-risk situation for the mother and the fetus
16. The problem of cardiac valve prostheses, anticoagulants, and pregnancy
17. Anticoagulation in pregnant women with mechanical heart valve prostheses
18. Embolic stroke in a pregnant patient with a mechanical heart valve on optimal heparin therapy
19. Efficacy of low-dose, subcutaneously administered heparin in treatment of pregnant women with artificial heart valves
20. Is there a safe anticoagulation protocol for pregnant women with prosthetic valves?
21. Cardiac embolism: The neurologist's perspective
22. The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves
23. Management of oral anticoagulant-induced intracranial haemorrhage
24. Treatment of warfarin-associated coagulopathy with oral vitamin K: A Randomised controlled trial
25. Age thresholds for prophylactic replacement of Björk-Shiley convexo-concave heart valves. A clinical and economic evaluation
26. Outlet strut fracture of the Björk-Shiley 60 degrees convexo- concave valve: Current information and recommendation for patient care
27. Should patients with Björk-Shiley valves undergo prophylactic replacement?
28. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report of the Veterans Affairs randomized trial
29. Fourteen-year experience with homovital homografts for aortic valve replacement
30. Allograft aortic valve replacement: Long-term follow-up
31. Degeneration in porcine bioprosthetic cardiac valves: Incidence of primary tissue failures among 938 bioprostheses at risk
32. Calcific degeneration as the main cause of porcine bioprosthetic valve failure
33. Outcome of pregnancy in women with valve prostheses
34. Twelve-year comparison of a Björk-Shiley mechanical heart valve with porcine bioprostheses
35. Actuarial versus actual risk of porcine structural valve deterioration
36. Ten-year experience with the porcine bioprosthetic valve: Interrelationship of valve survival and patient survival in 1,050 valve replacements
37. Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements
38. Hemodynamic and clinical impact of prosthesis patient mismatch in the aortic valve position and its prevention
39. Prosthesis-patient mismatch affects survival after aortic valve replacement
40. Thromboembolic complications of current cardiac valvular prostheses
41. Thrombosis of mechanical cardiac valves: A qualitative comparison of the silastic ball valve and the tilting disc valve
42. Systemic thromboembolism in mitral and aortic Starr-Edwards prostheses: A 10-19 year follow-up
43. A 5 1/2 year experience with the St. Jude Medical cardiac valve prosthesis. Early and late results of 737 valve replacements in 671 patients
44. Thrombolytic treatment of acute thrombotic obstruction with disk valve prostheses: Experience with 26 cases
45. Prediction of thrombus-related mechanical prosthetic valve dysfunction using transesophageal echocardiography
46. Transesophageal echocardiography for the diagnosis and management of nonobstructive thrombosis of mechanical mitral valve prosthesis
47. Reoperation on prosthetic heart valves. An analysis of risk factors in 552 patients
48. Predictors of operative survival after valve replacement
49. Thrombolytic therapy for obstruction of mechanical prosthetic valves
50. Fibrinolytic treatment of thrombus on prosthetic heart valves
51. Acute thrombotic obstruction with disc valve prostheses: Diagnostic considerations and fibrinolytic treatment
52. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings. Duke Endocarditis Service
53. Prosthetic valve disease
54. Early infective endocarditis on prosthetic valves
55. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study
56. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography
57. Comparison of transthoracic and transesophageal echocardiography for detection of abnormalities of prosthetic and bioprosthetic valves in the mitral and aortic positions
58. Value of transesophageal echocardiography as an adjunct to transthoracic echocardiography in evaluation of native and prosthetic valve endocarditis
59. Clinical impact of transesophageal echocardiography in the diagnosis and management of infective endocarditis